Karin Brown

650 total citations
3 papers, 12 citations indexed

About

Karin Brown is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Karin Brown has authored 3 papers receiving a total of 12 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Pharmacology. Recurrent topics in Karin Brown's work include Inflammatory mediators and NSAID effects (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Cancer Mechanisms and Therapy (1 paper). Karin Brown is often cited by papers focused on Inflammatory mediators and NSAID effects (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Cancer Mechanisms and Therapy (1 paper). Karin Brown collaborates with scholars based in United States. Karin Brown's co-authors include Jonathan L. Kaufman, Brandi Hilder, Duncan Walker, William Bensinger, Sagar Lonial, Robert Z. Orlowski, Gary P. Hingorani, Jeffrey A. Zonder, Kevin M. Koch and Adam D. Cohen and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Drug Metabolism and Disposition.

In The Last Decade

Karin Brown

3 papers receiving 12 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Brown United States	2	9	8	2	2	1	3	12
J Fagan Ireland	2	15 1.7×	5 0.6×	2 1.0×			2	18
Kaja Hoyer Denmark	2	7 0.8×	11 1.4×	5 2.5×			4	19
Robert Janicek United States	2	5 0.6×	11 1.4×	4 2.0×			3	16
Cody J. Boehner United States	2	9 1.0×	10 1.3×	2 1.0×			4	10
Ásdís Rósa Þórðardóttir Iceland	3	8 0.9×	12 1.5×	5 2.5×			3	17
Sophia Bustraan United Kingdom	2	8 0.9×	8 1.0×	4 2.0×			2	16
Reyes Sancho-Tello Spain	2	12 1.3×	11 1.4×	6 3.0×			2	20
Sidra Ellis United Kingdom	3	10 1.1×	9 1.1×	2 1.0×			5	10
M. Teresa Cibeira Spain	1	5 0.6×	4 0.5×	2 1.0×			3	5
Britton Zuccarelli United States	3	9 1.0×	2 0.3×	3 1.5×	2 1.0×		5	21

Countries citing papers authored by Karin Brown

Since Specialization

Citations

This map shows the geographic impact of Karin Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Brown more than expected).

Fields of papers citing papers by Karin Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Brown. The network helps show where Karin Brown may publish in the future.

Co-authorship network of co-authors of Karin Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Brown. A scholar is included among the top collaborators of Karin Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Brown. Karin Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Baer, Brian R., Karin Brown, Matthew G. McDonald, et al.. (2025). Novel O-methylpyrimidine prodrugs of phenolic compounds bioactivated by aldehyde oxidase: Enhancing metabolic stability against first-pass conjugative metabolism in the intestine. Drug Metabolism and Disposition. 53(4). 100059–100059. 1 indexed citations

2.

Ren, Li, David Moreno‐Mateos, Brian R. Baer, et al.. (2024). Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 67(15). 13019–13032. 1 indexed citations

3.

Tunquist, Brian, Karin Brown, Gary P. Hingorani, et al.. (2012). Identification of Alpha 1-Acid Glycoprotein (AAG) As a Potential Patient Selection Biomarker for Improved Clinical Activity of the Novel KSP Inhibitor ARRY-520 in Relapsed and Refractory Multiple Myeloma (MM). Blood. 120(21). 1868–1868. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact